References
- Brady J, Kashanchi F. Tat gets the “green” light on transcription initiation. Retrovirology 2005; 2: 69, [INFOTRIEVE], [CSA]
- Brew B J, Pemberton L, Blennow K, Wallin A, Hagberg L. CSF amyloid beta42 and tau levels correlate with AIDS dementia complex. Neurology 2005; 65: 1490–1492, [INFOTRIEVE], [CSA], [CROSSREF]
- Chang H C, Samaniego F, Nair B C, Buonaguro L, Ensoli B. HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparin sulfate proteoglycan through its basic region. AIDS 1997; 11: 1421–1431, [INFOTRIEVE], [CSA]
- Esiri M M, Biddolph S C, Morris C S. Prevalence of Alzheimer plaques in AIDS. J Neurol Neurosurg Psychiatry 1998; 65: 29–33, [INFOTRIEVE], [CSA]
- Green D A, Masliah E, Vinters H V, Beizai P, Moore D J, Achim C L. Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients. AIDS 2005; 19: 407–411, [INFOTRIEVE], [CSA], [CROSSREF]
- Hersh L B, Morihara K. Comparison of the subsite specificity of the mammalian neutral endopeptidase 24.11 (enkephalinase) to the bacterial neutral endopeptidase thermolysin. J Biol Chem 1986; 261: 6433–6437, [INFOTRIEVE], [CSA]
- Izycka-Swieszewska E, Zoltowska A, Rzepko R, Gross M, Borowska-Lehman J. Vasculopathy and amyloid beta reactivity in brains of patients with acquired immune deficiency (AIDS). Folia Neuropathol 2000; 38: 175–182, [INFOTRIEVE], [CSA]
- Jeang K T, Xiao H, Rich E A. Multifaceted activities of the HIV-1 transactivator of transcription, Tat. J Biol Chem 1999; 274: 28837–28840, [INFOTRIEVE], [CSA], [CROSSREF]
- Li C, Hersh L B. Neprilysin: assay methods, purification, and characterization. Methods Enzymol 1995; 248: 253–263, [INFOTRIEVE], [CSA]
- Liu Y, Jones M, Hingtgen C M, Bu G, Laribee N, Tanzi R E, Moir R D, Nath A, He J J. Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands. Nat Med 2000; 6: 1380–1387, [INFOTRIEVE], [CSA], [CROSSREF]
- Ma M, Nath A. Molecular determinants for cellular uptake of Tat protein of human immunodeficiency virus type 1 in brain cells. J Virol 1997; 71: 2495–2499, [INFOTRIEVE], [CSA]
- Mankowski J L, Queen S E, Tarwater P M, Fox K J, Perry V H. Accumulation of beta-amyloid precursor protein in axons correlates with CNS expression of SIV gp41. J Neuropathol Exp Neurol 2002; 61: 85–90, [INFOTRIEVE], [CSA]
- Mattson M P, Haughey N J, Nath A. Cell death in HIV dementia. Cell Death Differ 2005; 12(Suppl 1)893–904, [INFOTRIEVE], [CSA], [CROSSREF]
- McArthur J C, Brew B J, Nath A. Neurological complications of HIV infection. Lancet Neurol 2005; 4: 543–555, [INFOTRIEVE], [CSA], [CROSSREF]
- Nath A, Hersh L B. Tat and amyloid: multiple interactions. AIDS 2005; 19: 203–204, [INFOTRIEVE], [CSA], [CROSSREF]
- Quay T, Slaughter C, Davis T P, Merrill B J, Hersh L B. Positional effects in the neprilysin (neutral endopeptidase) reaction. Arch Biochem Biophys 1994; 308: 133–136, [INFOTRIEVE], [CSA], [CROSSREF]
- Ranga U, Shankarappa R, Siddappa N B, Ramakrishna L, Nagendran R, Mahalingam M, Mahadevan A, Jayasuryan N, Satishchandra P, Shankar S K, Prasad V R. Tat protein of human immunodeficiency virus type 1 subtype C strains is a defective chemokine. J Virol 2004; 78: 2586–2590, [INFOTRIEVE], [CSA], [CROSSREF]
- Rempel H C, Pulliam L. HIV-1 Tat inhibits neprilysin and elevates amyloid beta. AIDS 2005; 19: 127–135, [INFOTRIEVE], [CSA], [CROSSREF]
- Rumbaugh J, Galey D, Turchan-Cholewo J, Conant K, St. Hillaire C, Anderson C, Slevin R, Nath A. Interaction of HIV proteins and matrix metalloproteinases in HIV neuropathogenesis: new host defense mechanism. Ann Neurol 2005; 56: S70–71, [CSA]
- Schwarze S R, Ho A, Vocero-Akbani A, Dowdy S F. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 1999; 285: 1569–1572, [INFOTRIEVE], [CSA], [CROSSREF]
- Shinall H, Song E-S, Hersh L B. Susceptibility of amyloid beta peptide degrading enzymes to oxidative damage: a potential Alzheimer's disease spiral. Biochemistry 2005; 44: 15345–15350, [INFOTRIEVE], [CSA], [CROSSREF]
- Skoog I, Davidsson P, Aevarsson O, Vanderstichele H, Vanmechelen E, Blennow K. Cerebrospinal fluid beta-amyloid 42 is reduced before the onset of sporadic dementia: a population-based study in 85-year-olds. Dement Geriatr Cogn Disord 2003; 15: 169–176, [INFOTRIEVE], [CSA], [CROSSREF]
- Tornatore C, Meyers K, Atwood W, Conant K, Major E O. Temporal patterns of human immunodeficiency virus type 1 transcripts in human fetal astrocytes. J Virol 1994; 68: 93–102, [INFOTRIEVE], [CSA]
- Thompson M W, Govindaswami M, Hersh L B. Mutation of active site residues of the puromycin-sensitive aminopeptidase: conversion of the enzyme into a catalytically inactive binding protein. Arch Biochem Biophys 2003; 413: 236–242, [INFOTRIEVE], [CSA], [CROSSREF]
- Vanderstichele H, De Meyer G, Andreasen N, Kostanjevecki V, Wallin A, Olsson A, Blennow K, Vanmechelen E. Amino-truncated beta-amyloid42 peptides in cerebrospinal fluid and prediction of progression of mild cognitive impairment. Clin Chem 2005; 51: 1650–1660, [INFOTRIEVE], [CSA], [CROSSREF]
- Wesselingh S L, Glass J, McArthur J C, Griffin J W, Griffin D E. Cytokine dysregulation in HIV-associated neurological disease. Adv Neuroimmunol 1994; 4: 199–206, [INFOTRIEVE], [CSA]
- Westendorp M O, Frank R, Ochsenbauer C, Stricker K, Dhein J, Walczak H, Debatin K M, Krammer P H. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 1995; 375: 497–500, [INFOTRIEVE], [CSA], [CROSSREF]
- Zhang K, McQuibban G A, Silva C, Butler G S, Johnston J B, Holden J, Clark-Lewis I, Overall C M, Power C. HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor-1 causes neurodegeneration. Nat Neurosci 2003; 6: 1064–1071, [INFOTRIEVE], [CSA], [CROSSREF]